CRISPR IP deals explode; New VVC pool launched; BlackBerry patent sale latest; Ericsson cash boost for Apple fight; Time to prepare for the UPC
Everything we covered on IAM over the last seven days – and all you need to know from the global IP market to set yourself up for the start of another busy week
The Long Read
There are lessons to be learned from how digital-born businesses and industrial companies undergoing digital transformation approach data asset management, protection and value creation, write Marta Sadriu, Michelle Fransson and Bo Heiden. Read more here
MONDAY 24 January
The world’s top two laptop and tablet battery makers are squaring off against each other in a patent fight taking place in China. Read more here
The attorney and law firm representing Ericsson in its US patent litigation against Apple have very close ties to USPTO director nominee Kathi Vidal. Read more here
TUESDAY 25 January
Moderna, Nike and TSMC are among the patent owners that have gained the most momentum in terms of portfolio strength over the past two years, according to a new report. Read more here
With the UPC drawing ever nearer, companies face strategic IP dilemmas and must put new policies in place to reflect radical changes in Europe’s patent landscape. Read more here
Patent applicants may save legal costs by deferring responses on USPTO eligibility rejections, but the programme won’t improve examiner efficiency or fix the US patent eligibility law mess. Read more here
WEDNESDAY 26 January
Despite a 19% year-on-year drop in royalty receipts, Ericsson’s cash position has never been better as it digs in for a global patent litigation battle with Apple. Read more here
The political and practical cases for transparency around patent ownership are clear, says former USPTO head David Kappos. Read more here
THURSDAY 27 January
A new programme will see IoT chip designer Nordic Semiconductor offer its customers an upfront opportunity to license the Nokia cellular patent portfolio. Read more here
Japan Display Inc has announced that it and partner Panasonic have reached a cross licence agreement with China’s Tianma Microelectronics, bringing to an end a long-running patent dispute. Read more here
A new wave of litigation, pending challenges to AbbVie’s thicketing strategy and looming legislation mean this year could be a patent turning point for US biosimilars. Read more here
As the end of January approaches, it is reaching the now or never point for the long-promised BlackBerry patent sale. Read more here
FRIDAY 28 January
MPEG-LA has announced the formation of the second patent pool dedicated to the VVC video codec, with 11 licensors on board at launch. Read more here
There have been a slew of CRISPR IP deals this month, with several large pharmaceutical companies deepening their investments in cutting-edge gene-editing technologies. Read more here
How Doug Croxall, the former CEO of Marathon Patent Group, has built an innovative operating company based on patents previously owned by the NPE. Read more here
SATURDAY 29 January
Retention of IP, trade secrets and talent are increasingly the driving factors in big business decisions about where to conduct R&D and manufacturing. Read more here
